Factors include lower income, non-Hispanic White race, Medicaid/uninsured, greater distance to treatment centers
No evidence of different cardiovascular safety profiles seen for ustekinumab versus adalimumab, etanercept, secukinumab
Delgocitinib well tolerated and efficacious when used as needed in 36-week open-label trial
Risks for local recurrence, nodal metastases, distant metastases, disease-specific death increase as risk factor number increases
Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36
Many patients who achieved clear skin with tapinarof treatment maintained low disease activity after treatment-free interval
Agency says 90 percent of tested products have undetectable or extremely low levels of benzene
Memorial Sloan Kettering Cancer Center and Melanoma Institute of Australia models are most frequently externally validated
Both treatment approaches demonstrate achievement, maintenance of improvement of more than 90 percent in Eczema Area and Severity Index
Remibrutinib results in significant improvement in composite measure of itching and hives at week 12 after second-generation H1-antihistamine treatment
In this recurring column, Dermsquared and J.P. Morgan provide tailored financial strategies and investment insights for the dermatology community. Each 500-word article highlights key...
Increased risks seen based on twin cohort and case-cotwin studies
Review finds red, blue, and combination wavelength devices are all effective
Amjetiva and Imradi as effective as Humira for new users and in switcher analysis
HH-RCM can precisely identify surgical margins and is associated with a reduction in recurrence rates of lentigo maligna (melanoma)
Significant clinical improvements seen with and without induction therapy, with faster initial response with induction
However, less than half of parents support procedures even for mental health or bullying concerns
Children with obesity and specific comorbidities, including HTN and T2D, have increased risk for almost every skin condition
Misdiagnosis rates higher for the clinically amyopathic DM cohort versus DM cohort, with longer median diagnostic delays
Local recurrence rates lower compared with wide local excision, but no difference seen in regional, distant recurrence
Leave-on products linked to lower concentrations of benzene; increased concentrations seen in conditions consistent with hot processing
24 of 1238